… versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 …
J Guigay, A Aupérin, J Fayette, E Saada-Bouzid… - The Lancet …, 2021 - thelancet.com
… Platinum-based chemotherapy plus cetuximab in head and neck cancer. … versus cetuximab
with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck …
with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck …
[HTML][HTML] Biomarkers of cetuximab resistance in patients with head and neck squamous cell carcinoma
O Leblanc, S Vacher, C Lecerf, E Jeannot… - Cancer Biology & …, 2020 - ncbi.nlm.nih.gov
… Objective: In patients with head and neck squamous cell carcinoma (HNSCC), cetuximab
[a … While biomarkers of resistance to cetuximab have been identified in metastatic colorectal …
[a … While biomarkers of resistance to cetuximab have been identified in metastatic colorectal …
Cetuximab in locally advanced head and neck squamous cell carcinoma: Biological mechanisms involved in efficacy, toxicity and resistance
E Muraro, G Fanetti, V Lupato, V Giacomarra… - Critical Reviews in …, 2021 - Elsevier
… Currently, cetuximab associated with radiotherapy is limited to the … cetuximab efficacy in
this cancer setting are still lacking. This review focuses on the mechanisms of action of cetuximab…
this cancer setting are still lacking. This review focuses on the mechanisms of action of cetuximab…
[HTML][HTML] … with chemotherapy plus cetuximab in Chinese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: Efficacy and safety …
Y Guo, Y Luo, Q Zhang, X Huang, Z Li, L Shen… - … Journal of Cancer, 2021 - Elsevier
… new cases of head and neck cancers worldwide, with … percent of head and neck cancers are
squamous cell carcinoma (… {5-FU}] plus cetuximab followed by cetuximab maintenance until …
squamous cell carcinoma (… {5-FU}] plus cetuximab followed by cetuximab maintenance until …
Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised …
AG Sacco, R Chen, FP Worden, DJL Wong… - The Lancet …, 2021 - thelancet.com
… Pembrolizumab (PD-1 inhibitor) and cetuximab (EGFR … or metastatic head and neck squamous
cell carcinoma (HNSCC). … or metastatic squamous cell carcinoma of the head and neck …
cell carcinoma (HNSCC). … or metastatic squamous cell carcinoma of the head and neck …
Treatment sequence of cetuximab and immune checkpoint inhibitor in head and neck squamous cell carcinoma differentially affects outcomes
JC Park, J Durbeck, JR Clark, DL Faden - Oral Oncology, 2020 - Elsevier
… sequence of cetuximab and ICI in R/M HNSCC may affect clinical outcomes. Cetuximab
prior to ICI was associated with worse outcomes while the efficacy of cetuximab may be …
prior to ICI was associated with worse outcomes while the efficacy of cetuximab may be …
[HTML][HTML] Concurrent cisplatin or cetuximab with radiotherapy in patients with locally advanced head and neck squamous cell carcinoma: a meta-analysis
WH Tang, W Sun, GX Long - Medicine, 2020 - journals.lww.com
… Concurrent cisplatin with radiotherapy (CRT) or concurrent cetuximab with radiotherapy (BRT)
improves outcomes in locally advanced head and neck squamous cell carcinoma (…
improves outcomes in locally advanced head and neck squamous cell carcinoma (…
Cetuximab-based vs carboplatin-based chemoradiotherapy for patients with head and neck cancer
L Sun, D Candelieri-Surette… - … –Head & Neck …, 2022 - jamanetwork.com
… head and neck squamous cell carcinoma who are ineligible to receive treatment with cisplatin,
should cetuximab… with nonmetastatic head and neck squamous cell carcinoma treated …
should cetuximab… with nonmetastatic head and neck squamous cell carcinoma treated …
… efficacy and safety of radiotherapy/cetuximab versus radiotherapy/chemotherapy for locally advanced head and neck squamous cell carcinoma patients: a systematic …
M Mei, YH Chen, T Meng, LH Qu… - … in medical oncology, 2020 - journals.sagepub.com
… Cetuximab (CTX) has been approved to be administered concurrently with radiotherapy (RT)
to treat locally advanced head and neck squamous cell carcinoma (HNSCC). The aim of …
to treat locally advanced head and neck squamous cell carcinoma (HNSCC). The aim of …
… plus or minus cetuximab as first‐line treatment in a recurrent or metastatic (R/M) squamous cell carcinoma population of the head and neck (SCCHN), unfit for …
JC Ham, E van Meerten, WE Fiets, LV Beerepoot… - Head & …, 2020 - Wiley Online Library
… Head and neck cancer is the seventh most common cancer … advanced squamous cell
carcinoma of the head and neck (… this study was initiated was cetuximab added to platinum/5FU (…
carcinoma of the head and neck (… this study was initiated was cetuximab added to platinum/5FU (…